Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of [14C]-Anaprazole Sodium in Healthy Chinese Males
NCT04476394Phase 1Unknown
- Sponsor
- Sihuan Pharmaceutical
- Start
- Aug 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of anaprazole sodium in duodenal ulcer and reflux esophagitis, sponsored by Sihuan Pharmaceutical. Primary endpoints: Maximum Observed Concentration (Cmax) of Anaprazole (Total Radioactivity) at 168 hours, Time to Maximum Concentration (Tmax) of Anaprazole (Total Radioactivity) at 168 hours and 6 more. Status: unknown.
02
Drugs
anaprazole sodium
03
Conditions
duodenal ulcerreflux esophagitis
Beyond the preview
Go deeper on NCT04476394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476394.